Abrdn Life Sciences Investors (HQL)

HQL Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2022	FY 2021	FY 2020
Period Ending	Feb 23, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	496	448	412	343	505	413
Market Cap Growth	-	8.58%	20.08%	-31.99%	22.27%	20.21%
Enterprise Value	496	448	422	352	505	413
Last Close Price	16.77	14.57	12.38	9.08	12.65	9.85
PE Ratio	5.80	5.23	4.84	-	7.83	3.36
PS Ratio	256.07	231.02	103.63	113.77	220.89	121.78
PB Ratio	0.97	0.87	0.90	0.86	0.97	0.85
P/TBV Ratio	0.97	0.87	0.90	0.86	0.97	0.85
P/OCF Ratio	15.65	14.12	-	-	-	-
EV/Sales Ratio	256.03	231.02	105.98	116.55	220.89	121.78
Debt / Equity Ratio	-	-	-	0.03	0.02	0
Net Debt / Equity Ratio	0	0	0	0.03	0.02	0
Asset Turnover	0.00	0.00	-	0.01	0.00	0.01
Quick Ratio	0.71	0.71	0.27	0.04	0.01	0.28
Current Ratio	0.73	0.73	0.32	0.70	0.80	8.88
Return on Equity (ROE)	17.59%	17.59%	-	-22.71%	12.82%	28.38%
Return on Assets (ROA)	-0.43%	-0.43%	-	-0.39%	-0.51%	-0.30%
Return on Capital Employed (ROCE)	-0.70%	-0.70%	-0.40%	-0.80%	-0.80%	-0.40%
Earnings Yield	17.24%	19.11%	20.68%	-30.45%	12.78%	29.79%
Dividend Yield	10.85%	12.50%	13.41%	16.19%	13.20%	14.93%
Payout Ratio	66.05%	36.96%	-	-	-	-
Buyback Yield / Dilution	-5.48%	-5.48%	-9.28%	-4.10%	-3.29%	-3.03%
Total Shareholder Return	5.37%	7.02%	4.13%	12.09%	9.91%	11.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q